Dynamic Deconstructive Psychotherapy Versus Brief Intervention and Contact for Suicidal Adolescents and Young Adults

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-40
SponsorState University of New York - Upstate Medical University

About this trial

The purpose of this clinical trial is to assess whether 6 months of treatment with Dynamic Deconstructive Psychotherapy (DDP) is more effective for reducing thoughts of suicide in suicidal adolescents and young adults than usual care in the community supplemented with Brief Intervention and Contact (BIC). DDP and BIC are two evidence-based practices shown to be more effective than usual care at reducing suicidality. Participants will be randomly assigned to receive DDP treatment with safety planning and optional medication management or BIC treatment with safety planning and optional medication management. Participants in both groups will receive the assigned treatment at SUNY Upstate Medical University's Psychiatry High Risk Program (PHRP). Each participant is anticipated to take part in this trial for up to one year.

Eligibility criteria

Qualifiers

CSSRS suicide ideation of ≥ 2 and PHQ-9 item 9 of ≥ 1

Ages 14 through 40 years old of both genders

Fluency in English

Willingness to enter outpatient treatment as evidenced by psychiatric consultation at the PHRP and attending a first session with their intake therapist

Disqualifiers

Previous or current clinical diagnosis of schizophrenia, schizoaffective disorder or autism spectrum disorder as ascertained by self-report on the PHRP intake packet, or on their electronic medical records, or by psychiatric evaluation at the PHRP

BMI < 18 for adults ≥ 18 years old, and BMI < 17 for adolescents

Concurrent use of weekly ECT, ketamine, or esketamine

IQ < 80 on the Peabody Picture Vocabulary Test

Trial design

Treatments tested in this trial

  • Dynamic Deconstructive Psychotherapy (DDP)
  • Brief Intervention and Contact (BIC)

Treatment groups

106 Participants
are divided into 2 treatment groups